Brought to you by 
Shenzhen Hepalink Pharma goes public
07 May 2010
Executive Summary
In the highest ever IPO done on China's A-share market, Shenzhen Hepalink Pharmaceutical Co. Ltd. (manufactures heparin) has raised Yuan Renminbi 5.9bn ($868mm) through the sale of 40.1mm shares for Yuan Renminbi 148 apiece.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Shenzhen Hepalink Pharma goes public
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice